A randomized, double-blind, placebo-controlled trial of recombinant human α-interferon therapy for chronic non-A, non-B (type C) hepatitis
- 31 December 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 11, S36-S42
- https://doi.org/10.1016/0168-8278(90)90161-j
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Diagnosis of AlcoholismMedical Clinics of North America, 1988
- ALPHA-INTERFERON THERAPY FOR NON-A, NON-B HEPATITIS TRANSMITTED BY GAMMAGLOBULIN REPLACEMENT THERAPYThe Lancet, 1987
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Non-A, Non-B Posttransfusion Hepatitis—A Decade LaterGastroenterology, 1985
- Sporadic Non-A, Non-B Hepatitis: Frequency and Epidemiology in an Urban U.S. PopulationThe Journal of Infectious Diseases, 1982
- Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.Gut, 1982
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981